High-dose chemotherapy of breast cancer with hematopoietic protection; current status and prospectives
Antimi, M.
La Clinica Terapeutica 149(921): 7-9
1998
ISSN/ISBN: 0009-9074 PMID: 9621481 Document Number: 497173
Document emailed within 1 workday
Related Documents
Bearman, S.I.; Shpall, E.J.; Jones, R.B.; Cagnoni, P.J.; Ross, M. 1996: High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer Seminars in Oncology 23(1 Suppl 2: 60-67Filip, S.; Petera, J.; Odrázka, K.; Bláha, M. 2000: The current look at high-dose chemotherapy in breast cancer minireview Neoplasma 47(5): 261-268
Kaminer, L.S.; Williams, S.F.; Beschorner, J.; O'Brien, S.; Golick, J.; Bitran, J.D. 1989: High dose chemotherapy with autologous hematopoietic stem cell support in the treatment of refractory stage IV breast carcinoma Bone Marrow Transplantation 4(4): 359-362
Kotz, K.W.; Schilder, R.J. 1995: High-dose chemotherapy and hematopoietic progenitor cell support for patients with epithelial ovarian cancer Seminars in Oncology 22(3): 250-262
Razis, E.D.; Samonis, G.; Cook, P.; Beer, M.; Mittelman, A.; Lake, D.E.; Feldman, E.J.; Puccio, C.; Ahmed, T. 1994: TMJ: a well-tolerated high-dose regimen for the adjuvant chemotherapy of high risk breast cancer Journal of Medicine 25(3-4): 241-250
Leonard, R.C. 1998: High-dose chemotherapy in metastatic breast cancer Lancet 351(9107): 986
Marzetti, L.; Framarino Dei Malatesta, M.; Yacoub, M.; Veneziano, M.; Bandiera, A.F.; Fiorelli, C.; Felici, A. 1997: Neoadjuvant chemotherapy in the treatment of breast cancer. Results and prospectives Minerva Ginecologica 49(9): 393-397
Toh, H.C. 2000: High dose chemotherapy in breast cancer--a thin red line between hype and hope Singapore Medical Journal 41(2): 86-88
Meropol, N.J.; Overmoyer, B.A.; Stadtmauer, E.A. 1992: High-dose chemotherapy with autologous stem cell support for breast cancer Oncology 6(12): 53-60; 63; Discussion: 63-4 69
Kennedy, M.J. 1997: Issues relating to the inclusion of high-dose chemotherapy in breast cancer treatment guidelines Oncology 11(11a): 121-126
Bertucci, F.; Viens, P.; Gravis, G.; Blaise, D.; Faucher, C.; Oziel-Taoeb, S.; Bardou, V.J.; Jacquemier, J.; Delpero, J.R.; Maraninchi, D. 1999: High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: analysis of 67 patients treated in a single institution Anticancer Research 19(2b): 1455-1461
de Graaf, H.; Mulder, N.H.; Willemse, P.H.; van der Graaf, W.T.; Sleijfer, D.T.; Zijlstra, J.G.; Elias, M.; Sibinga, C.T.; Vellenga, E.; de Vries, E.G. 1995: The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease Anticancer Research 15(6B): 2851-2856
Stemmler, H.J.; Salat, C.; Lindhofer, H.; Menzel, H.; Untch, M.; Kahlert, S.; Konecny, G.; Sauer, H.; Ledderose, G.; Heinemann, V.; Kolb, H.J. 2005: Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study Anticancer Research 25(4): 3047-3054
Rühl, U. 2000: Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(4): 196-197
Gianni, A.M.; Bregni, M.; Siena, S.; Tarella, C. 1989: Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy Haematologica 74(5 Suppl): 511-526
Chen, T.L.; Passos-Coelho, J.L.; Noe, D.A.; Kennedy, M.J.; Black, K.C.; Colvin, O.M.; Grochow, L.B. 1995: Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation Cancer Research 55(4): 810-816
Lucey, C.; Westphal, J.R. 1998: New approach to administrative medical decision-making: evidence-based medicine using high dose chemotherapy/bone marrow transplant for breast cancer Southern Medical Journal 91(2): 196-201
Sola, C.; Mendoza, L.; Amill, B.; Mesía, R.; Rueda, A.; Alonso, M.C.; Ojeda, B.; Artigas, V.; Tugues, D.; García, J. 1995: Intensive chemotherapy with support of peripheral hematopoietic progenitor cells, mobilized with high-dose cyclophosphamide and G-CSF: fast hematologic recovery Revista Clinica Espanola 195(2): 83-88
Purdy, M.H. 1995: Positive selection and ex vivo expansion of hematopoietic progenitors as autografts for high-dose chemotherapy, potential importance in patients with bone metastases Canadian Journal of Oncology 5 Suppl. 1: 63-68
Gaspar, N.; Boudou, P.; Haroche, J.; Wechsler, B.; Van Den Neste, E.; Hoang-Xuan, K.; Amoura, Z.; Guillevin, R.; Savatovski, J.; Azar, N.; Piette, J-Charles.; Leblond, Véronique. 2006: High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation for adult histiocytic disorders with central nervous system involvement Haematologica 91(8): 1121-1125